Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Tromantadine: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 466409152 of page Tromantadine for the Chem/Drugbox validation project (updated: 'CAS_number'). |
consistent citation formatting |
||
Line 1: | Line 1: | ||
{{Short description|Antiviral medicine used to treat herpes simplex virus}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Tromantadine|oldid=466409152}} 466409152] of page [[Tromantadine]] with values updated to verified values.}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| alt = Skeletal formula |
| alt = Skeletal formula |
||
| image2 = Tromantadine-3D-balls.png |
|||
| alt2 = Ball-and-stick model |
|||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = Viru-Merz |
||
| Drugs.com = {{drugs.com|international|tromantadine}} |
| Drugs.com = {{drugs.com|international|tromantadine}} |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_US = Not FDA-approved |
|||
| legal_status = |
|||
| legal_status = [[Over-the-counter drug|OTC]] <small>([[Russia|RU]])</small> |
|||
| routes_of_administration = [[Topical]] |
| routes_of_administration = [[Topical]] ([[gel]]) |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| metabolism = |
| metabolism = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite| |
| CAS_number_Ref = {{cascite|changed|??}} |
||
| CAS_number = |
| CAS_number = 53783-83-8 |
||
| ATC_prefix = D06 |
| ATC_prefix = D06 |
||
| ATC_suffix = BB02 |
| ATC_suffix = BB02 |
||
| ATC_supplemental = {{ATC|J05|AC03}} |
|||
| PubChem = 64377 |
| PubChem = 64377 |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 57947 |
| ChemSpiderID = 57947 |
||
| NIAID_ChemDB = 007760 |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = H191JFG8WA |
| UNII = H191JFG8WA |
||
| KEGG_Ref = {{keggcite|correct|kegg}} |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
| KEGG = D07199 |
| KEGG = D07199 |
||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=16 | H=28 | N=2 | O=2 |
| C=16 | H=28 | N=2 | O=2 |
||
⚫ | |||
| molecular_weight = 280.406 [[Gram|g]]/[[Mole (unit)|mol]] |
|||
⚫ | |||
| InChI = 1/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19) |
|||
| InChIKey = UXQDWARBDDDTKG-UHFFFAOYAP |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19) |
| StdInChI = 1S/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19) |
||
Line 44: | Line 41: | ||
| StdInChIKey = UXQDWARBDDDTKG-UHFFFAOYSA-N |
| StdInChIKey = UXQDWARBDDDTKG-UHFFFAOYSA-N |
||
}} |
}} |
||
'''Tromantadine''' is an [[antiviral medicine]] used to treat [[herpes simplex virus]]. It is available in a [[Topical gels|topical gel]] under trade names '''Viru-Merz''' and '''Viru-Merz Serol'''. Its performance is similar to [[aciclovir]].<ref>{{cite journal | vauthors = Ostheimer KE, Busch T, Görtelmeyer R, Hahn KD | title = Randomized double-blind trial of tromantadine versus aciclovir in recurrent herpes orofacialis | journal = Arzneimittel-Forschung | volume = 39 | issue = 9 | pages = 1152–1155 | date = September 1989 | pmid = 2686658 }}</ref><ref>{{cite journal | vauthors = Diezel W, Michel G, Görtelmeyer R, Ostheimer KE | title = Efficacy of tromantadine and aciclovir in the topical treatment of recurrent herpes orofacialis. Comparison in a clinical trial | journal = Arzneimittel-Forschung | volume = 43 | issue = 4 | pages = 491–496 | date = April 1993 | pmid = 8494582 }}</ref> |
|||
Like [[rimantadine]], [[amantadine]], and [[adapromine]], tromantadine is a derivative of [[adamantane]]. |
|||
==Mechanism== |
|||
Tromantadine inhibits the early and late events in the [[virus]] replication cycle.<ref name="pmid6297383">{{cite journal | vauthors = Rosenthal KS, Sokol MS, Ingram RL, Subramanian R, Fort RC | title = Tromantadine: inhibitor of early and late events in herpes simplex virus replication | journal = Antimicrobial Agents and Chemotherapy | volume = 22 | issue = 6 | pages = 1031–1036 | date = December 1982 | pmid = 6297383 | pmc = 185716 | doi = 10.1128/aac.22.6.1031 }}</ref> It changes the [[glycoprotein]]s of the host cells, therefore impeding the absorption of the virus. It inhibits penetration of the virus. It also prevents [[uncoating]] of the [[virion]]s.{{cn|date=November 2022}} |
|||
== References == |
|||
{{Reflist|2}} |
|||
== External links == |
|||
* [https://web.archive.org/web/20050429203941/http://www.brookespharma.com/brands_virumerz_main.htm Viru-Merz website] |
|||
{{Antibiotics and chemotherapeutics for dermatological use}} |
|||
{{Antivirals}} |
|||
[[Category:Anti-herpes virus drugs]] |
|||
[[Category:Adamantanes]] |
|||
[[Category:Acetamides]] |
|||
[[Category:Dimethylamino compounds]] |
|||
{{antiinfective-drug-stub}} |
|||
{{dermatologic-drug-stub}} |